Suraksha Diagnostic, a prominent player in the diagnostic industry, is set to open its IPO for subscription on November 29, 2024. Offering a price band of ₹420–₹441 per equity share, the IPO has garnered significant attention due to the company’s robust operational network and strong financial performance.
Key Details About the IPO
- IPO Dates: Opens on November 29, 2024, and closes on December 3, 2024.
- Price Band: ₹420 to ₹441 per share.
- Lot Size: 34 shares and multiples thereof.
- IPO Type: Entirely an Offer for Sale (OFS) of up to 19,189,330 equity shares.
Operational and Financial Highlights
- Operational Strength:
Suraksha Diagnostic operates through a centralized hub-and-spoke model, ensuring efficiency and reliability in its services. Its network includes:- 1 flagship central reference laboratory.
- 8 satellite laboratories.
- 215 customer touchpoints, including diagnostic centers and sample collection points.
- Financial Growth:
The company reported significant growth in its financials:- Revenue growth of 14.75% (FY23–FY24).
- Profit after Tax (PAT) surged by 281.32% during the same period.
Grey Market Premium (GMP) Trends
The IPO’s GMP reflects the anticipation in the market. Currently:
- November 28: ₹0 (at par with the issue price).
- The lack of a premium suggests stable demand, with expectations of performance tied to the company’s fundamentals rather than speculative trading.
How Suraksha Diagnostic Stands Among Peers
A comparative analysis with industry leaders highlights its potential:
| Company | P/E Ratio | Revenue Growth (%) | PAT Growth (%) |
|---|---|---|---|
| Dr. Lal PathLabs | 77.08 | 11.2 | 85.3 |
| Metropolis Healthcare | 89.61 | 10.8 | 78.5 |
| Suraksha Diagnostic | 65.52 | 14.75 | 281.32 |
| Thyrocare | 65.52 | 9.3 | 65.7 |
What Makes This IPO Stand Out
- Strategic presence in key regions like West Bengal, Bihar, Assam, and Meghalaya.
- Proven track record in pathology and radiology services.
- Established growth trajectory supported by operational efficiency.
MUST READ: Enviro Infra Engineers IPO: Allotment Status, GMP Trends & Easy Online Check
Conclusion
Suraksha Diagnostic IPO presents an opportunity for investors looking to tap into the growing healthcare sector. Its strong financials, coupled with an expansive network, make it a compelling prospect. However, investors should consider market conditions and personal investment goals before subscribing.
Disclaimer:
This article is for informational purposes only. Consult with a certified financial advisor for investment decisions.
